1. Stocks
  2. Aurobindo Pharma Ltd.
  3. Swot
Aurobindo Pharma Ltd. SWOT Analysis: Strengths, Weakness, Opportunity, and Threats
Stocks where Mutual Funds Increased Holdings in Past Month
Strong Annual EPS Growth
Efficient in managing Assets to generate Profits - ROA improving since last 2 year
Growth in Quarterly Net Profit with increasing Profit Margin (YoY)
Company with Low Debt
Company able to generate Net Cash - Improving Net Cash Flow for last 2 years
Annual Net Profits improving for last 2 years
Book Value per share Improving for last 2 years
Company with decreasing Promoter pledge
FII / FPI or Institutions increasing their shareholding
MFs increased their shareholding last quarter
Big Deal (Insider and SAST) sells last month greater than 1% of total shares
Negative Breakdown First Support (LTP < S1)
Broker downgrades in price or recommendation in the past one month
Bearish Stocks - Stocks with Medium to Low Trendlyne Momentum Score 86.4% returns for Nifty 500 over 4.5 years
Inefficient use of capital to generate profits - RoCE declining in the last 2 years -9.0% returns for Nifty 500 over 1.9 years
Decline in Net Profit (QoQ)
Decline in Quarterly Net Profit (YoY)
Declining Revenue every quarter for the past 3 quarters
Declining profits every quarter for the past 2 quarters
Promoter decreasing their shareholding
Fall in Quarterly Revenue and Net Profit (YoY)
Weak Momentum: Price below Short, Medium and Long Term Averages
High promoter stock pledges
Buy Zone: Stocks in the buy zone based on days traded at current PE and P/BV
Companies with current TTM PE Ratio less than 3 Year, 5 Year and 10 Year PE
Undervalued Growth Stocks 468.8% returns for Nifty 500 over 5.9 years
Expert Stock Screener: Benjamin Graham Value Screen 202.3% returns for Nifty 500 over 6.4 years
Best Bargains Screener: Above line growth, Below line valuations 258.5% returns for Nifty 500 over 6.4 years
Expert Stock Screener: Jim Slater's Zulu Principle (Discover Growth Stocks)
Stock with Low PE (PE < = 10)
Recent Broker Downgrades in Reco or Target Price
Indian stocks that could be impacted by Brexit (Britain leaving the EU)
Red Flags: Firms linked to ongoing regulatory investigations/legal cases -26.5% returns for over 0.8 years
Increasing Trend in Non-Core Income
US FDA Warning Letter
Red Flag: Companies seeing significant coronavirus impact
Insiders sold stocks
Strong Performer, Under Radar Stocks (DVM) 1941.9% returns for Nifty 500 over 8.4 years
Average Affordability - Stocks with Medium Trendlyne Valuation Score versus Benchmarks 211.8% returns for Nifty 500 over 4.5 years
Highest FII stock holdings 32.8% returns for over 6.4 years
RSI indicating price weakness
Delivery Screener: 20% Higher Delivery over the Week compared to Month
Top Losers